Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis

References

• Boushey C. J., Beresford S. A. A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995; 274: 1049–57
   PubMed Web of Science ®Google Scholar
• Solomon D. H., Karlson E. W., Rimm E. B., Cannuscio C. C., Mandl L. A., Manson J. E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303–7
   PubMed Web of Science ®Google Scholar
• Roubenoff R., Dellaripa P., Nadeau M. R., Leslie W. A., Bernadette A. M., Jacob S., et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 1997; 40: 718–22
   PubMed Web of Science ®Google Scholar
• Krogh Jensen M., Ekelund S., Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis. Scand J Clin Lab Invest 1996; 56: 421–9
   PubMed Web of Science ®Google Scholar
• Cardiel M. H., Abello‐Banfi M., Ruiz‐Mercado R., Alarcon‐Segovia D. How to measure health status in rheumatoid arthritis in non‐English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ‐Di). Clin Exp Rheumatol 1993; 11: 117–21
   PubMed Web of Science ®Google Scholar
• Hochberg M. C., Chang R. W., Dwosh I., Lindsey S., Pincus T., Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498–502
   PubMed Web of Science ®Google Scholar
• Selhub J., Jacques P. F., Rosenberg I. H., Rogers G., Bowman B. A., Gunter E. W., et al. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991–1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999; 131: 331–9
   PubMed Web of Science ®Google Scholar
• Canto J. G., Taylor H. A Jr., Rogers W. J., Sanderson B., Hilbe J., Barron H. V. Presenting characteristics, treatment patterns, and clinical outcomes of non‐black minorities in the National Registry of Myocardial Infarction 2. Am J Cardiol 1998; 82: 1013–18
   PubMedGoogle Scholar
• Whincup P. H., Refsum H., Perry I. J., Morris R., Walker M., Lennon L., et al. Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 1999; 82: 448–54
   PubMed Web of Science ®Google Scholar
• Ueland P. M., Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989; 114: 473–501
   PubMed Web of Science ®Google Scholar
• Jensen O. K., Rassmussen C., Mollerup F., Christensen P. B., Hansen H., Ekelund S., et al. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation. J Rheumatol 2002; 29: 1615–18
   PubMedGoogle Scholar
• Hornung N., Ellingsen T., Stengaard‐Pedersen K., Poulsen J. H. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. J Rheumatol 2004; 31: 2374–81
   PubMed Web of Science ®Google Scholar
• Haagsma C. J., Blom H. J., van Riel P. L. M. C., van't Hof M. A., Giesendorf B. A. J., van Oppenraaij‐Emmerzaal D., et al. Influence of sulphasalazine, methotrexate, and combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 1999; 58: 79–84
   PubMed Web of Science ®Google Scholar
• Esfahani S. T., Cogger E. A., Caudill M. A. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 2003; 103: 200–7
   PubMed Web of Science ®Google Scholar
• Hoekstra M., Haagsma C. J., Doelman C. J. A., van de Laar M. A. F. J. Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate. Ann Rheum Dis 2005; 64: 141–3
   PubMedGoogle Scholar